Carbenicillin Resistance in Pseudomonas aeruginosa from Clinical Material
- 19 July 1969
- Vol. 3 (5663), 141-143
- https://doi.org/10.1136/bmj.3.5663.141
Abstract
Strains of Pseudomonas aeruginosa resistant to 256 μg. per ml. or more of carbenicillin (Pyopen) were isolated from 17 patients over a period of three months. The infections were not solely due to cross-infection. Low dosage and attempted eradication of the organism from inaccessible sites, such as the bronchi or skin surfaces, by using systemic treatment are two possible causes. Restraint in treating infections of doubtful importance and the use of local applications to appropriate sites with or without systemic treatment is suggested.Keywords
This publication has 6 references indexed in Scilit:
- THE TREATMENT OF INFECTIONS DUE TO PSEUDOMONAS AERUGINOSA WITH CARBENICILLIN (“PYOPEN”)The Medical Journal of Australia, 1968
- Experiences with carbenicillin in the treatment of septicaemia and meningitisPublished by Oxford University Press (OUP) ,1968
- CLINICAL AND LABORATORY STUDIES WITH CARBENICILLIN A New Penicillin Active against Pseudomonas pyocyaneaThe Lancet, 1967
- BACTERIOLOGICAL OBSERVATIONS ON CARBENICILLIN IN CONTROL OF PSEUDOMONAS AERUGINOSA INFECTION IN BURNS1967
- Typing of Pseudomonas pyocyanea by pyocine productionThe Journal of Pathology and Bacteriology, 1966
- Reactions of Bacteria to Chemotherapeutic AgentsBMJ, 1951